ArticleJAAD case reports2020
Treatment of granuloma annulare with tofacitinib 2% ointment.
Article in JAAD case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Rapid and Successful Treatment of Interstitial Granulomatous Dermatitis With Tofacitinib: A Case Report.Clinical case reports · 2026Article
- Localized granuloma annulare successfully treated with ruxolitinib.JAAD case reports · 2026Article
- [Clinical variables and management of disseminated granuloma annulare - monocentric retrospective analysis of 33 cases between 2021 and 2023].Dermatologie (Heidelberg, Germany) · 2025Article
- Ruxolitinib cream for the treatment of granuloma annulare.JAAD case reports · 2024Article
- Successful Treatment of Refractory Generalized Granuloma Annulare with Upadacitinib.Case reports in dermatological medicine · 2024Article
- Molecularly Targeted Therapies for Inflammatory Cutaneous Granulomatous Disorders: A Review of the Evidence and Implications for Understanding Disease Pathogenesis.JID innovations : skin science from molecules to population health · 2023Review
- Macrophage Biology in Human Granulomatous Skin Inflammation.International journal of molecular sciences · 2023Review
- Treatment of granuloma annulare with tofacitinib.The Australasian journal of dermatology · 2022Article
- Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options.American journal of clinical dermatology · 2022Review
- Treatment of cutaneous sarcoidosis with tofacitinib 2% ointment and extra virgin olive oil.JAAD case reports · 2021Article
- Improvement of granulomatous skin conditions with tofacitinib in three patients: A case report.SAGE open medical case reports · 2021Article
- Generalized granuloma annulare: A widespread response to limited application of compounded 2% topical tofacitinib.JAAD case reports · 2020Article
- The Promise of JAK Inhibitors for Treatment of Sarcoidosis and Other Inflammatory Disorders with Macrophage Activation: A Review of the Literature.The Yale journal of biology and medicine · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.